🇺🇸 FDA
Patent

US 9023858

Substituted pyrido[2,3-d]pyrimidines as delta-5-desaturase inhibitors

granted A61PA61P1/00A61P1/04

Quick answer

US patent 9023858 (Substituted pyrido[2,3-d]pyrimidines as delta-5-desaturase inhibitors) held by Takeda Pharmaceutical Company Limited expires Mon Apr 30 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Takeda Pharmaceutical Company Limited
Grant date
Tue May 05 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 30 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
12
CPC classes
A61P, A61P1/00, A61P1/04, A61P1/16, A61P11/00